This group unites PH patients, caregivers, researchers and medical professionals in a platform to discuss the latest research and medical advances related to pulmonary hypertension. Information shared in this group is public.
On Tuesday, Medtronic announced receipt of FDA approval of their Implantable System for Remodulin (ISR). Composed of the company’s implantable drug infusion pump and a newly developed intravascular catheter, the system will deliver Remodulin intravenously to patients who have been receiving Remodulin through an external infusion pump. Read more about it on our news site, or straight from Medtronic’s press release.
Those of you on Remodulin, would you consider transitioning to an implanted pump? I know some patients have been anxiously awaiting its release. I listened to presentations about the possibility of implanted pumps years ago at PH Conferences before I had my transplant.
Pulmonary Hypertension News is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.